Clinical Trial

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to elucidate the therapeutic efficacy of electroacupuncture in managing chemotherapy-induced gastrointestinal symptom clusters through clinical research. Building upon this foundation, multi-omics analyses will be conducted to investigate the regulatory effects and underlying mechanisms of electroacupuncture on gastrointestinal symptoms. Ultimately, genomic studies will be performed to further clarify the key targets of electroacupuncture intervention, thereby providing high-level evidence-based medical support and theoretical foundations for optimizing electroacupuncture strategies in addressing chemotherapy-induced gastrointestinal symptoms in patients with cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-23; most recent amendment 2026-07-09.
Status change: Not Yet Recruiting → Recruiting 2025-12-08
Trial Details
NCT Number NCT06952920
Lead Sponsor Jiuda Zhao
Conditions Standard Quadruple Antiemetic Therapy, Electroacupuncture, Chemotherapy-induced Gastrointestinal Symptom Cluster
Enrollment 388 participants
Start Date 2025-08-21
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-10